Evidence map›Paper›PMID 31119302›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2019

TNF-α/calreticulin dual signaling induced NLRP3 inflammasome activation associated with HuR nucleocytoplasmic shuttling in rheumatoid arthritis.

Yixin Liu, Wei Wei, Yang Wang, Chunyou Wan, Yingyu Bai, Xuguo Sun, Jun Ma, Fang Zheng

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Alleviated NCOA4-mediated ferritinophagy protected RA FLSs from ferroptosis in lipopolysaccharide-induced inflammation under hypoxia.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Relationship between HuR and tumor drug resistance.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yixin LiuDepartment of Clinical Immunology, School of Medical Laboratory, Tianjin Medical University, Tianjin, 300203, China.
Wei WeiDepartment of Rheumatology, General Hospital, Tianjin Medical University, Tianjin, 300052, China.
Yang WangDepartment of Clinical Immunology, School of Medical Laboratory, Tianjin Medical University, Tianjin, 300203, China.
Chunyou WanCenter of Joint Surgery, Tianjin Hospital, Tianjin, 300210, China.
Yingyu BaiDepartment of Clinical Immunology, School of Medical Laboratory, Tianjin Medical University, Tianjin, 300203, China.
Xuguo SunDepartment of Clinical Immunology, School of Medical Laboratory, Tianjin Medical University, Tianjin, 300203, China.
Jun MaDepartment of Health Statistics, College of Public Health, Tianjin Medical University, Tianjin, 300070, China. majun@tmu.edu.cn.
Fang ZhengDepartment of Clinical Immunology, School of Medical Laboratory, Tianjin Medical University, Tianjin, 300203, China. fangzheng@tmu.edu.cn.ORCID http://orcid.org/0000-0003-1731-261X
Tianjin Medical University · CNTianjin Hospital · CNTianjin Medical University General Hospital · CN

Funding

Natural Science Foundation of Tianjin City 14JCYBJC25600
6 · The paper itself

Abstract

objectiveThe present study was undertaken to validate whether TNF-α and calreticulin (CRT) serve as dual signaling to activate nucleotide-binding oligomerization domain-, leucine-rich repeat- and pyrin domain-containing 3 (NLRP3) inflammasome in rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS) and HUVECs. The effect of human antigen R (HuR) in NLRP3 inflammasome activation was also explored in RA FLS.

methodsImmunofluorescence was used to determine the expression of NLRP3 and adaptor protein apoptosis associated speck-like protein containing a CARD (ASC) in RA synovial tissue and HuR location in RA FLS. Western blot and quantitative real-time PCR were employed to measure the priming effect of NLRP3 inflammasome in cells and HuR expression in synovial tissue. The concentrations of IL-1β and IL-18 were detected by enzyme linked immunosorbent assay. Immunohistochemistry was used to visualize the expression of HuR in synovial tissue. HuR knockdown in RA FLS was achieved by siRNA-mediated gene silencing.

resultsHigher expression of NLRP3 and ASC in RA synovial tissue than those in osteoarthritis was detected. The staining of NLRP3, ASC and cleaved IL-1β were observed in FLS and vascular endothelial cells in RA synovium. Expression of NLRP3 and pro-IL-1β in RA FLS and HUVECs treated with TNF-α was increased. The pro-IL-18 expression was also enhanced in HUVECs, but not in RA FLS. TNF-α/CRT dual stimulation of cells gave rise to caspase-1 p20 expression and the secretion of IL-1β. The secreted IL-18 was also elevated in HUVECs but not in RA FLS. HuR expression was significantly elevated in RA synovial tissue. TNF-α initiated the nucleocytoplasmic shuttling of HuR in both FLS and HUVECs. The knockdown of HuR in FLS incubated with TNF-α led to reduced caspase-1 p20 protein expression and further resulted in decreased secretion of IL-1β in the presence of CRT.

conclusionsTNF-α/CRT dual signaling induced NLRP3 inflammasome activation, which could be suppressed by HuR knockdown presumably due to the block of HuR translocating from nucleus to cytoplasma.

Indexed as

Arthritis, RheumatoidCalreticulinELAV-Like Protein 1HumansHuman Umbilical Vein Endothelial CellsInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinSignal TransductionSynovial MembraneSynoviocytesTumor Necrosis Factor-alphaCalreticulinCALR protein, humanELAVL1 protein, humanELAV-Like Protein 1InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanTumor Necrosis Factor-alphaCalreticulinFibroblast-like synoviocytesHuman antigen RNLRP3 inflammasomeRheumatoid arthritisTumor necrosis factor-α

Identifiers

PMID31119302
OpenAlexW2945250552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.